198 related articles for article (PubMed ID: 11764381)
41. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
42. Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis.
Einspahr JG; Alberts DS; Warneke JA; Bozzo P; Basye J; Grogan TM; Nelson MA; Bowden GT
Neoplasia; 1999 Nov; 1(5):468-75. PubMed ID: 10933063
[TBL] [Abstract][Full Text] [Related]
43. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
44. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
45. P53 and hMSH2 expression in basal cell carcinomas and malignant melanomas from photoexposed areas of head and neck region.
Staibano S; Lo Muzio L; Pannone G; Somma P; Farronato G; Franco R; Bambini F; Serpico R; De Rosa G
Int J Oncol; 2001 Sep; 19(3):551-9. PubMed ID: 11494035
[TBL] [Abstract][Full Text] [Related]
46. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
[TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
Ichikawa E; Watanabe S; Otsuka F
Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
[TBL] [Abstract][Full Text] [Related]
48. Epithelial expression of extracellular matrix metalloproteinase inducer/CD147 and matrix metalloproteinase-2 in neoplasms and precursor lesions derived from cutaneous squamous cells: An immunohistochemical study.
Ayva SK; Karabulut AA; Akatli AN; Atasoy P; Bozdogan O
Pathol Res Pract; 2013 Oct; 209(10):627-34. PubMed ID: 23948694
[TBL] [Abstract][Full Text] [Related]
49. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
Wrone DA; Yoo S; Chipps LK; Moy RL
Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
[TBL] [Abstract][Full Text] [Related]
50. The actinic keratosis. A perspective and update.
Schwartz RA
Dermatol Surg; 1997 Nov; 23(11):1009-19; quiz 1020-1. PubMed ID: 9391557
[TBL] [Abstract][Full Text] [Related]
51. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
[TBL] [Abstract][Full Text] [Related]
52. Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors.
Hirai K; Kumakiri M; Fujieda S; Sunaga H; Lao LM; Imamura Y; Ueda K; Fukuda M
J Dermatol Sci; 2001 Apr; 25(3):179-88. PubMed ID: 11240265
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical localization of the neutral cysteine protease bleomycin hydrolase in human skin.
Takeda A; Nonaka M; Ishikawa A; Higuchi D
Arch Dermatol Res; 1999 Apr; 291(4):238-40. PubMed ID: 10335922
[No Abstract] [Full Text] [Related]
54. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
[TBL] [Abstract][Full Text] [Related]
55. Expression of proliferating cell nuclear antigen (PCNA) and apoptosis related antigen (LeY) in epithelial skin tumors.
Tsuji T; Kitajima S; Koashi Y
Am J Dermatopathol; 1998 Apr; 20(2):164-9. PubMed ID: 9557786
[TBL] [Abstract][Full Text] [Related]
56. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
[TBL] [Abstract][Full Text] [Related]
57. P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Blokx WA; de Jong EM; de Wilde PC; Bulten J; Link MM; Ruiter DJ; van de Kerkhof PC
Mod Pathol; 2003 Sep; 16(9):869-78. PubMed ID: 13679450
[TBL] [Abstract][Full Text] [Related]
58. Premalignant and early squamous cell carcinoma.
Butani AK; Arbesfeld DM; Schwartz RA
Clin Plast Surg; 2005 Apr; 32(2):223-35. PubMed ID: 15814119
[TBL] [Abstract][Full Text] [Related]
59. Cell proliferation and p53 protein expressions in cutaneous epithelial neoplasms.
Onodera H; Nakamura S; Sugai T
Am J Dermatopathol; 1996 Dec; 18(6):580-8. PubMed ID: 8989929
[TBL] [Abstract][Full Text] [Related]
60. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
Fernandez-Flores A
Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
